___

• Das, B., Rajarao, AVS., Sonalı, R., Yadav, A., Ray, A., Pandya, M., Rattan, A., Mehta, A. (2009). Synthesis and biological activity of novel oxazolidinones. Bioorganical and Medicinal Chemistry Letters, 19, 6424-6428.
• Desai, K.R., Mistry, R.N. (2005). Studies on Synthesis of Some Novel Heterocyclic Azlactone Derivatives and Imidazolinone Derivatives and their Antimicrobial Activity. E-Journal Chemistry, 2, 42-51.
• El-Gohary, N.S., Shaaban, M.I. (2017). Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. European Journal of Medicinal Chemistry, 137, 439-449.
• Zhu, M., Gokhale, V.M., Szabo, L., Munoz, R.M., Baek, H., Bashyam, S., Hurley, L.H., Von Hoff, D.D., Han, H. (2007). Identification of a novel inhibitor of urokinase-type plasminogen activator. Molecular Cancer Theraphy, 6, 1348-1356.
• Kuzikov, A.V., Dugin, N.O., Stulov, S.V., Shcherbinin, D.S., Zharkova, M.S., Tkachev, Y.V.,Timofeev, V.P., Veselovsky, A.V., Shumyantseva, V.V., Misharin, A.Y. (2014) Novel oxazolinyl derivatives of pregna- 5,17(20)-diene as 17α-hydroxylase/17,20-lyase (CYP17A1) inhibitors. Steroids, 88, 66-71.
• Diacon, A.H., Groote-Bidlingmanier, F., Donald, P.R. (2014). A new 6-nitro-2,3-dihydroimidazo-[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampisin. Expert Opinion on Orphan Drugs, 2, 87-94.
• Garg, P., Chaudhary, S., Milton, M.D. (2014) Synthesis of 2-Aryl/Heteroaryloxazolines from Nitriles under Metal and Catalyst-Free Conditions and Evaluation of Their Antioxidant Activities. Journal of Organic Chemistry, 79, 8668−8677.
• Temiz-Arpaci, O., Coban, T., Tekiner-Gulbas, B., Can-Eke, B., Yildiz, I., Aki-Sener, E., Yalcin, I., Iscan, M.A. (2006). Study on the antioxidant activities of some new benzazole derivatives. Acta Biologica Hungarica, 57, 201-209.
• Mariappan, G., Saha, B.P., Datta, S., Kumar, D., Haldar, P.K. (2011) Design, synthesis and antidiabetic evaluation of oxazolone derivatives. Journal of Chemical Science, 123, 335-334.
• Brickner, S.J., Hutchinson, D.K., Barbachyn, M.R., Manninen, P.R., Ulanowicz, D.A., Garmon, K.C., Hendges, S.K., Toops, D.S., Ford, C.W., Zurenko, G.E. (1996). Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections. Journal of Medicinal Chemistry, 39, 673-679.
• Kuş, C., Uğurlu, E., Özdamar, E.D., Can-Eke, B. (2017). Synthesis and Antioxidant Properties of New Oxazole-5(4H)-one Derivatives. Turkish Journal of Pharmaceutical Sciences, 14(2), 174-178.
• NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. NCCLS document. M7-A5. NCCLS.
• Wayne, P.A. (2012). CLSI. Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically; Approved Standard 9 Th Edition. CLSI Document M07-A9: Clinical and Laboratory Standards Institute.
• Wayne, P.A. (2015). Performance Standards For Antimicrobial Disk Susceptibility Tests; Approved Standard 12th Edition, CLSI Document, M02, A12.